EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Total Expenditure History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹6,427 Cr | ₹5,429 Cr | ₹4,805 Cr | ₹4,525 Cr | ₹4,824 Cr |
What is the latest Total Expenditure of EMCURE PHARMACEUTICALS ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹6,427 Cr |
| Mar2024 | ₹5,429 Cr |
| Mar2023 | ₹4,805 Cr |
| Mar2022 | ₹4,525 Cr |
| Mar2021 | ₹4,824 Cr |
How is Total Expenditure of EMCURE PHARMACEUTICALS Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,427 Cr | 18.40 | |
| Mar2024 | ₹5,429 Cr | 12.99 | |
| Mar2023 | ₹4,805 Cr | 6.17 | |
| Mar2022 | ₹4,525 Cr | -6.20 | |
| Mar2021 | ₹4,824 Cr | - | |
Compare Total Expenditure of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹34,326.2 Cr | -0.3% | 4.3% | 44.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,507.0 Cr | 2.8% | 7.4% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹190,744.0 Cr | 6.4% | 8.3% | 0.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹168,250.0 Cr | 2.1% | 8.7% | 47.7% | Stock Analytics | |
| CIPLA | ₹116,213.0 Cr | 0.5% | 3.6% | -5.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,980.0 Cr | -7.6% | -2.2% | -5.8% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -0.3% |
4.3% |
44.2% |
| SENSEX | -1.4% |
4.4% |
-7.6% |
You may also like the below Video Courses